Endpoints News 生物医药· ENDPOINTS·· 18 天前AI 评分26
uniQure 获 FDA 审评日期与咨询委员会审核;Inovio 股价上涨
UniQure gets review date and adcomm; Inovio's stock surges after approval
AI 导读
FDA 给予 uniQure 一个审评日期并安排咨询委员会审核,Inovio 股价因获批消息上涨。
正文
Plus news about AbbVie, Gilead and Tiziana Life Sciences.
FDA gives uniQure a review date and adcomm: The agency will decide whether or not to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news